Cracow, Poland

Jan Potempa


 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jan Potempa: Innovator in Periodontal Treatment

Introduction

Jan Potempa is a notable inventor based in Cracow, Poland. He has made significant contributions to the field of dental medicine, particularly in the treatment of periodontal diseases. His innovative work has led to the development of a unique patent that addresses critical health issues.

Latest Patents

Jan Potempa holds a patent for "Bacterial glutaminyl cyclases and inhibitors thereof for use in the treatment of periodontitis." This invention relates to bacterial glutaminyl cyclases and their inhibitors, which are essential for treating periodontitis and related conditions. The patent provides a bacterial glutaminyl cyclase (bacQC), an antibody that recognizes the bacQC, and methods for identifying inhibitors of the bacQC. Additionally, it includes a compound according to Formula (I) and a pharmaceutical composition comprising a bacQC inhibitor compound. This invention is aimed at improving therapeutic methods for bacterial infections and addressing acute, chronic, or recurrent periodontal diseases.

Career Highlights

Jan Potempa is associated with the Fraunhofer Gesellschaft zur Förderung der angewandten Forschung e.V., where he continues to advance research in his field. His work has garnered attention for its potential impact on dental health and treatment methodologies.

Collaborations

Jan has collaborated with notable colleagues, including Sigrun Eick and Nadine Taudte, who contribute to the research and development of innovative solutions in dental medicine.

Conclusion

Jan Potempa's contributions to the field of periodontal treatment through his innovative patent highlight the importance of research in improving health outcomes. His work exemplifies the intersection of science and practical application in addressing significant health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…